JoAnn Suzich
Chief Tech/Sci/R&D Officer at IMMUNOCORE HOLDINGS PLC
Profile
JoAnn Suzich is currently the Head of Research at Immunocore Holdings Plc.
Previously, she served as an Independent Director at Evaxion Biotech A.
From 2017 to 2019, she held the position of Vice President of Research & Development at MedImmune LLC.
In 2018 and 2019, she was the Head of the Microbial Sciences Therapeutic Area at AstraZeneca PLC.
Dr. Suzich completed her undergraduate and graduate degrees at Susquehanna University and obtained a doctorate from Purdue University.
JoAnn Suzich active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Chief Tech/Sci/R&D Officer | 2020-03-31 |
Former positions of JoAnn Suzich
| Companies | Position | End |
|---|---|---|
| EVAXION BIOTECH A/S | Director/Board Member | 2021-05-24 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 2019-06-30 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Chief Tech/Sci/R&D Officer | 2018-12-31 |
Training of JoAnn Suzich
| Purdue University | Doctorate Degree |
| Susquehanna University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| EVAXION BIOTECH A/S | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| IMMUNOCORE HOLDINGS PLC | Health Technology |
| Private companies | 1 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
- Stock Market
- Insiders
- JoAnn Suzich
